Company: LNAI
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001731122-25-001544
Chunk: 1

Company: Lunai Bioworks Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 1
Chunk 1
---
Convertible notes payable

245,000

245,000

Current portion of operating lease liabilities

277,775

313,047

Notes payable, net

1,038,495

3,580,525

Notes payable – related parties, net

866,661

5,610,372

Total Current Liabilities

19,722,474

29,156,134

NON-CURRENT LIABILITIES:

Operating lease liabilities, net of current portion

278,963

424,547

Total Non-Current Liabilities

278,963

424,547

Total Liabilities

20,001,437

29,580,681

STOCKHOLDERS’ DEFICIT

Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding

—

—

Common stock, par value $0.0001, 350,000,000 shares authorized, 23,180,277 shares issued and outstanding at September 30, 2025; 17,739,291 shares issued and outstanding at June 30, 2025

2,318

1,774

Additional paid-in capital

494,728,618

478,296,113

Accumulated deficit

(507,643,549
)

(510,462,570
)

Accumulated other comprehensive (loss)

(128,161
)

10,814,842

Total Stockholders’ Deficit

(13,040,774
)

(21,349,841
)

TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT
 
$
6,960,663

$
8,230,840

See accompanying notes to the unaudited condensed consolidated
financial statements.

2

LUNAI BIOWORKS INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)

For the Three Months Ended

September 30,

2025
 
2024

Operating Expenses

General and administrative
 
$
2,410,516

$
5,301,251

Research and development

24,407

390,189

Goodwill impairment

—

47,614,729

Long-lived asset impairment

831,915

—

Depreciation and amortization

41,522

32,385

Total Operating Expenses

3,308,360

53,338,554

LOSS FROM OPERATIONS

(3,308,360